Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) chief medical officer Marie-Louise Fjällskog updates Proactive's Thomas Warner the clinical-stage biopharmaceutical company's wholly-owned precision immunotherapy asset, Bexmarilimab.
Fjällskog says that she's "looking forward to a year filled with good data for the patients."
Contact Details
Proactive UK Ltd
Proactive UK Ltd
+44 20 7989 0813
